In glioma, NEAT1 could specifically bind to miR-449b-5p and miR-181d-5p to inhibit their transcriptions, leading to the over-expression of oncogenes c-Met and SOX5, respectively [19, 41]. This evidence concerns the gene NEAT1 and central nervous system cancer.